Real-life data over 36 weeks of guselkumab treatment in psoriasis patients: A single-center study from Turkey.

Eda Öksüm SolakFatih Can AbaSalih Levent ÇınarDemet KartalMurat Borlu

Published in: Journal of cosmetic dermatology (2024)

This study includes real-life data on the use of guselkumab therapy for psoriasis in the Turkish population. Based on the results, guselkumab is a highly effective and safe treatment.

Keyphrases

end stage renal disease
electronic health record
ejection fraction
newly diagnosed
chronic kidney disease
combination therapy
deep learning